Research about severely ill COVID-19 patients on ICU with the main focus on bacterial and fungal infectious events

Research about severely ill COVID-19 patients on ICU with the main focus on bacterial and fungal infectious events - EpiVent

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00027266

Enrollment

1951

Registered

2021-12-01

Start date

2021-02-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1

Interventions

Group 1: observational study of critically ill COVID 19 patients. Sub-groups are formed regarding to therapy and potential risk factors (age, sex, pre existing illness) and then compared with each oth

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: COVID 19 infection with need of intensive care

Exclusion criteria

Exclusion criteria: time on ICU took place before COVID infection

Design outcomes

Primary

Measure	Time frame
COVID-19 infection with need for ICU	—

Secondary

Measure	Time frame
invasive measurements: mechanical ventilation, catheters; laboratory proof of a bacterial infection	—

Countries

Germany

Contacts

Public ContactCathrin Kodde

Emil-von-Behring KrankenhausABS und Infektiologie

cathrin.kodde@helios-gesundheit.de030810262495

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026